US2017259073A1PendingUtilityA1

Bioelectronic medical system for cancer treatment

Assignee: NEURO CODE TECH HOLDINGS LLCPriority: Mar 12, 2014Filed: Mar 21, 2017Published: Sep 14, 2017
Est. expiryMar 12, 2034(~7.6 yrs left)· nominal 20-yr term from priority
Inventors:Eleanor Schuler
A61N 1/36017A61N 1/205A61N 1/32A61N 1/37235
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A process, method, and devices thereof for the rapid destruction of cancer tumor(s) which are made up of thousands to millions of living malignant cancer cells. Such an approach seeks to kill said tumor(s) by causing apoptosis or excitotoxicity and/or osmotic-shock within a human or animal for medical treatment

Claims

exact text as granted — not AI-modified
1 . A bioelectronic medical system for the rapid destruction of cancer cells, said system comprising:
 an electronic device for recording signals of an intrinsic cellular electrical pattern associated with cancer cells and then reprogramming said signals to shut down an operation signal system associated with said cancer cells;   an A-D (Analog-to-Digital) converter and a D-A (Digital-to-Analog) converter;   a reaction chamber that encloses said cancer cells in a water-tight sealed non-metallic compartment, wherein said reaction chamber is sealed during a cancer killing process with respect to said cancer cells; and   at least one reactive material employed within said reaction chamber to destroy said cancer cells, wherein arterial blood vessels feeding said cancer cells are clamped during said medical procedure to prevent contamination of other body structures by said at least one reactive material used in said reaction chamber.   
     
     
         2 . The system of  claim 1  wherein said signals are initially recorded as analog signals: 
     
     
         3 . The system of  claim 2  wherein said at least one reactive material comprises saturated calcium C++ compounds. 
     
     
         4 . The system of  claim 2  wherein said at least one reactive material comprises at least one of: de-ionized and/or ionized water, and glutamate transporters that can accommodate excitotoxic reaction pathways. 
     
     
         5 . The system of  claim 2  wherein said at least one reactive material comprises saturated calcium C++ compounds and de-ionized water. 
     
     
         6 . The system of  claim 2  wherein said at least one reactive material comprises saturated calcium C++ compounds and ionized water. 
     
     
         7 . The system of  claim 2  wherein said at least one reactive material comprises saturated calcium C++ compounds and glutamate transporters that accommodate excitotoxic reaction pathways. 
     
     
         8 . (canceled) 
     
     
         9 . The system of  claim 2  wherein said signals that are initially recorded as said analog signals are thereafter transformed by said A-D converter into a digital format for said reprogramming of said signals. 
     
     
         10 . The system of  claim 9  wherein after said reprogramming of signals in said digital format, said signals are converted from said digital format into an analog format to shut down said operation signal system associated with said cancer cells. 
     
     
         11 . The system of  claim 1  wherein said reprogramming of said signals results in signals that initiate programmed-cell-death with respect to said tumor by apoptosis. 
     
     
         12 . The system of  claim 1  wherein said reprogramming of said signals results in signals that initiate programmed-cell-death with respect to said tumor by karyorrhexis. 
     
     
         13 . The system of  claim 10  wherein said signals after reprogramming and conversion from said digital formal into said analog format comprise treatment signals. 
     
     
         14 . The system of  claim 1  wherein said electronic device comprises a hybrid scientific computer. 
     
     
         15 . The system of  claim 14  wherein said hybrid scientific computer communicates electronically with a network of servers. 
     
     
         16 . The system of  claim 14  wherein said hybrid scientific computer communicates wirelessly with a network of servers. 
     
     
         17 . The system of  claim 2  wherein said reprogramming of said signals results in signals that initiate programmed-cell-death with respect to said tumor by apoptosis. 
     
     
         18 . The system of  claim 2  wherein said reprogramming of said signals results in signals that initiate programmed-cell-death with respect to said tumor by karyorrhexis.

Join the waitlist — get patent alerts

Track US2017259073A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.